Cite
HARVARD Citation
Rasmussen, R. et al. (n.d.). Phase I lead‐in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour‐bearing dogs. Veterinary and comparative oncology. pp. 421-430. [Online].